Skincare Compound Madecassic Acid Shows Promise Against Drug-Resistant Bacteria

What Is Madecassic Acid And Why Does It Matter For Drug-Resistant Infections?

Madecassic acid is one of several active triterpenoid compounds extracted from Centella asiatica, a herb long used in traditional Asian medicine and, more recently, popularized in Korean skincare for its skin-soothing and barrier-repair properties. Laboratory investigations now suggest that its biological activity extends well beyond cosmetic benefits. Researchers have observed that the compound can interfere with how bacteria protect themselves against antibiotics, including by disrupting efflux pumps and membrane-associated resistance mechanisms that many multidrug-resistant pathogens rely on.

The clinical importance of this finding lies in the growing crisis of antimicrobial resistance (AMR). According to estimates published by the World Health Organization and in The Lancet, AMR is directly associated with well over a million deaths each year and contributes to several million more. With few novel antibiotic classes reaching the market in recent decades, so-called antibiotic adjuvants — molecules that don't kill bacteria outright but make them vulnerable again to existing drugs — have become an increasingly important research strategy. Madecassic acid fits this profile.

How Could A Skincare Ingredient Become A Future Infection Treatment?

Compounds like madecassic acid have a head start in drug development because decades of topical use in cosmetics and traditional medicine have already generated substantial human safety data. That doesn't mean oral or intravenous formulations are automatically safe — systemic exposure is very different from topical use — but it does mean researchers have a baseline understanding of the molecule's chemistry and tolerability. The next steps typically involve animal infection models, pharmacokinetic studies, and combination testing with specific antibiotics to identify which resistant pathogens respond best.

Public health experts caution that these findings, while promising, are preclinical. Consumers should not interpret the discovery as a reason to self-treat infections with skincare products or Centella asiatica supplements. The effective doses, delivery routes, and safety margins needed for infection control are fundamentally different from cosmetic applications. Still, the research underscores a broader trend in pharmacology: some of the most promising leads against superbugs may come from plants and compounds already hiding in plain sight.